111 Inc
YI6.760USD
-0.160-2.31%
Market hours （ET）Quotes delayed by 15 min
342.56MMarket Cap
LossP/E TTM
More Details of 111 Inc Company
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Company Info
Ticker SymbolYI
Company name111 Inc
IPO dateSep 12, 2018
CEOMr. Junling Liu
Number of employees1238
Security typeDepository Receipt
Fiscal year-endSep 12
Address3-4/F, No.295 Zuchongzhi Road
CitySHANGHAI
Stock exchangeNASDAQ Global Market Consolidated
CountryChina
Postal code201203
Phone862120536666
Websitehttp://corporate.111.com.cn/
Ticker SymbolYI
IPO dateSep 12, 2018
CEOMr. Junling Liu
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: CNYUpdated: Sun, Jul 6
Currency: CNYUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessCNY
Name
Revenue
Proportion
Product Revenues
3.51B
99.44%
Service Revenues
19.70M
0.56%
No Data
By Business
By Region
By BusinessCNY
Name
Revenue
Proportion
Product Revenues
3.51B
99.44%
Service Revenues
19.70M
0.56%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
ClearVue Partners
15.64%
First Pharmacia International
8.57%
6 Dimensions Capital Ltd.
7.15%
Zall Capital Ltd
2.82%
Tongyi Investment Holding Ltd
2.13%
Other
63.69%
Shareholders
Shareholders
Proportion
ClearVue Partners
15.64%
First Pharmacia International
8.57%
6 Dimensions Capital Ltd.
7.15%
Zall Capital Ltd
2.82%
Tongyi Investment Holding Ltd
2.13%
Other
63.69%
Shareholder Types
Shareholders
Proportion
Corporation
15.84%
Private Equity
15.64%
Venture Capital
7.15%
Investment Advisor
0.32%
Hedge Fund
0.25%
Investment Advisor/Hedge Fund
0.22%
Research Firm
0.11%
Other
60.47%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
48
2.00M
39.53%
-385.56K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
2023Q3
57
2.15M
44.81%
-47.43K
2023Q2
64
2.05M
43.37%
+895.26K
2023Q1
77
2.20M
46.58%
+971.22K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
ClearVue Partners
792.41K
15.64%
--
--
Feb 27, 2024
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
6 Dimensions Capital Ltd.
362.30K
7.15%
--
--
Feb 27, 2024
Zall Capital Ltd
143.12K
2.82%
--
--
Feb 27, 2024
Tongyi Investment Holding Ltd
107.78K
2.13%
--
--
Feb 27, 2024
Allied China Investment Ltd
94.97K
1.87%
--
--
Feb 27, 2024
J.P. Morgan Trust Company of Delaware
22.17K
0.44%
--
--
Feb 27, 2024
Renaissance Technologies LLC
12.81K
0.25%
-531.00
-3.98%
Mar 31, 2025
Connor, Clark & Lunn Investment Management Ltd.
11.34K
0.22%
+11.34K
--
Mar 31, 2025
Deuterium Capital Management, LLC
10.00K
0.2%
+10.00K
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
Invesco Golden Dragon China ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
Proportion0%
SPDR S&P Emerging Asia Pacific ETF
Proportion0%
Invesco Golden Dragon China ETF
Proportion0%
SPDR S&P Emerging Markets Small Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Date
Type
Ratio
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
